Introduction
Material and Methods
Medication and Preparation
Treatment Procedure
Imaging Follow-up
Imaging Evaluation
Clinical Follow-up
Results
Patient Inclusion
Technical Procedure
Demography | Overall | Female | Male |
Sex | 81 | 55 | 26 |
Age (years) | 58.1 ± 11.9 (16–85) | 57.9 ± 10.2 (16–85) | 58.7 ± 12.7 (35–77) |
Aneurysm anatomy | |||
Aneurysm size (mm) | 4.6 ± 2.4 (2.0–12.5) | ||
Dome/neck ratio | 1.06 ± 0.22 | ||
Location | ACA: 43; MCA: 18; PCA/BA: 14; PCA: 5; PICA: 1 |
Procedural Safety
Initial Occlusion Rate
Procedure (n = 81) | |
Stents used | 86 |
Stent alone | 1 (stent-in-stent) |
Stent-assisted coiling | 80 (n = 1 T-stenting, n = 3 > 1 stent used) |
Jailing/through mesh | 74/6 |
Initial occlusion rate | MRRCi1: n = 42; 51.9%/MRRCi2: n = 9; 11.1%/MRRCi3a: n = 20; 24.7%/MRRCi3b: n = 10; 12.3% |
Adverse events | Acute stent thrombosis: n = 1 (1.2%) |
DWI/FLAIR lesions (non-symptomatic): n = 14 (17.3%) | |
DWI/FLAIR lesions (symptomatic): none | |
Hemorrhage: n = 1 (1.2%, coil-associated) | |
Mortality | None |
Follow-up (n = 76) | |
Interval | 7.2 ± 1.6 (5–11) months |
Modality | DSA: n = 76; FD-CT + MRI: n =5 |
Occlusion DSA n = 76 | MRRC6M1: n = 60; 78.9%/MRRC6M2: n = 3; 3.9%/MRRC6M3a: n = 5; 6.6%/MRRC6M3b: n = 8; 10.5% |
Adverse events | Delayed stent thrombosis: n = 1 (1.8%) |
DWI/FLAIR lesions (non-symptomatic): none | |
DWI/FLAIR lesions (symptomatic): 1 (1.8%) | |
Hemorrhage: none | |
Endothelial hyperplasia: n = 2 (3.5%) | |
Recurrence: none | |
Mortality | None |